1. Home
  2. GRTS

GRTS

Gritstone bio Inc.

Logo Gritstone bio Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.

Founded: 2015 Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: 107.5M IPO Year: 2018
Target Price: $6.33 AVG Volume (30 days): 2.9M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.20 EPS Growth: N/A
52 Week Low/High: $0.83 - $3.33 Next Earning Date: 05-09-2024
Revenue: $16,344,000 Revenue Growth: -18.05%
Revenue Growth (this year): -12.86% Revenue Growth (next year): 239.07%

Share on Social Networks: